1Lohr M,Maisonneuve P,Lowenfels AB. K-ras mutations and benigh pancreatic disease. Int J Pancreatol, 2000,27: 93-103.
2Mler P,Jesnowski R,Liebe S,et al. Simple method for DNA extraction from pancreatic juice for PCR amplification assays. Int J Pancreatol, 1999,25: 39-43.
3Hruban RH,Mansfeld A,Offerhaus G, et al. K ras oncogene acti vation in adenocarcinoma of the human pancreas. Am J Pathol,1993,143:545-554.
4Lüttges J,Diederichs A, Vogel I,et al. Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53. Cancer, 2000,88: 2495-2504.
5Berger D,Chang H,Wood M, et al. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesion in relation to cigarette smoking status. Cancer, 1999,326-332.
6Lohr M,Muller P,Mora J,et al.p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis[].Gastrointestinal Endoscopy.2001
7Ferrari-Junior AP,Lichtenstein DR,Slivka A,et al.Brush cytology during ERCP for the diagnosis of biliary and pancreatic malignancies[].Gastrointestinal Endoscopy.1994
8Hruban RH,Van-Mansfeld AD,Offerhaus GJ,et al.K-ras oncogene activation in adenocarcinoma of the human pancreas[].American Journal of Pathology.1993
9Cerny WL,Mangold KA,Scarpelli DG.K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster[].Cancer Research.1992
10Van-Laethem JL,Vertongen P,Deviere J,et al.Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours[].Gut.1995
3Shah RJ, Langer DA, Antillon MR, et al. Cholangioscopy and cholangioscopic forceps biopsy in patients with indeterminate pancreaticobiliary pathology[ J]. Clin Gastroenterol Hepatol, 2006, 4 (2) :219-225.
4Myung SJ, Kim MH, Kim YS, et al. Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation[J]. Gastrointest Endosc, 2000, 51 (6) :708-713.
5Levi S,Urbano-Ispizua A, Gill R, et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique[J]. Cancer Res, 1991,6(51 ) : 3497-3502.
6Chen CY, Shiesh SC, Wu SJ. Rapid detection of K-ras mutations in bile by peptide nucleic acid-mediated PCR clamping and melting curve analysis: comparison with restriction fragment length polymorphism analysis [ J ]. Clin Chem, 2004, 50 (3) :481-489.
7Saurin JC, Joly-Pharaboz MO, Pemas P, et al. Detection of Ki-ras gene point mutations in bile specimens for the differential diagnosis of malignant and benign biliary strictures[J]. Gut, 2000, 47(3) : 357-361.
8Itoi T, Shinohara Y, Takeda K, et al. Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers[ J].Gastrointest Endosc, 2000, 52(3 ) :380-386.
9Jailwala J, Fogel EL, Sherman S, et al. Triple-tissue sampling at ERCP in malignant biliary obstruction [ J ]. Gastrointest Endosc, 2000, 51(4) :383-390.
10Prat F, Chapat O, Ducot B, et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct[ J]. Gastrointest Endosc, 1998, 7( 1 ) : 1-2.
